AURORA 2: Aurinia Renal Response in Lupus With Voclosporin

Trial Profile

AURORA 2: Aurinia Renal Response in Lupus With Voclosporin

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2018

At a glance

  • Drugs Voclosporin (Primary)
  • Indications Lupus nephritis
  • Focus Adverse reactions; Registrational
  • Acronyms AURORA2
  • Sponsors Aurinia Pharmaceuticals
  • Most Recent Events

    • 25 Jun 2018 According to an Aurinia Pharmaceuticals media release, first patients has been enrolled in this extension study.
    • 17 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top